Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Selective Screening Study to Investigate the Frequency of Neuronal Ceroid Lipofuxinosis Type 2 (CLN2) in the Presence of Nonspecific Neurological Findings Accompanying Seizures Between the Ages of 2 and 6

NCT06128226 is registered in ClinicalTrials.gov with Nadir Hastalıkları Araştırma Derneği as lead sponsor.

NCT NCT06128226
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06128226 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Selective Screening Study to Investigate the Frequency of Neuronal Ceroid Lipofuxinosis Type 2 (CLN2) in the Presence of Nonspecific Neurological Findings Accompanying Seizures Between the Ages of 2 and 6
Lead sponsor
Nadir Hastalıkları Araştırma Derneği
Phase
Observational
Overall status
Recruiting
Start date
September 6, 2023
Completion date
March 31, 2025
Enrollment
750 (estimated)
Sites
34

Conditions

As the registry lists them; a condition with its own page is linked.

neuronal ceroid lipofuxinosis type2 (cln2)